336 related articles for article (PubMed ID: 34747516)
1. Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial.
Tsujita M; Doi Y; Obi Y; Hamano T; Tomosugi T; Futamura K; Okada M; Hiramitsu T; Goto N; Isaka Y; Takeda A; Narumi S; Watarai Y
J Bone Miner Res; 2022 Feb; 37(2):303-311. PubMed ID: 34747516
[TBL] [Abstract][Full Text] [Related]
2. Effect of 16-weeks vitamin D replacement on calcium-phosphate homeostasis in overweight and obese adults.
Mesinovic J; Mousa A; Wilson K; Scragg R; Plebanski M; de Courten M; Scott D; Naderpoor N; de Courten B
J Steroid Biochem Mol Biol; 2019 Feb; 186():169-175. PubMed ID: 30367939
[TBL] [Abstract][Full Text] [Related]
3. Influence of vitamin D supplementation on bone mineral content, bone turnover markers, and fracture risk in South African schoolchildren: multicenter double-blind randomized placebo-controlled trial (ViDiKids).
Middelkoop K; Micklesfield LK; Walker N; Stewart J; Delport C; Jolliffe DA; Mendham AE; Coussens AK; van Graan A; Nuttall J; Tang JCY; Fraser WD; Cooper C; Harvey NC; Hooper RL; Wilkinson RJ; Bekker LG; Martineau AR
J Bone Miner Res; 2024 Apr; 39(3):211-221. PubMed ID: 38477739
[TBL] [Abstract][Full Text] [Related]
4. Effect of Oral Vitamin D3 Supplementation in Exclusively Breastfed Newborns: Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
Lin CH; Lin CY; Sung YH; Li ST; Cheng BW; Weng SL; Chang SJ; Lee HC; Lee YJ; Ting WH; Chang HY; Wu YL; Lin CS
J Bone Miner Res; 2022 Apr; 37(4):786-793. PubMed ID: 35122668
[TBL] [Abstract][Full Text] [Related]
5. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
[TBL] [Abstract][Full Text] [Related]
6. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.
Chandra P; Binongo JN; Ziegler TR; Schlanger LE; Wang W; Someren JT; Tangpricha V
Endocr Pract; 2008; 14(1):10-7. PubMed ID: 18238736
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.
Giusti A; Barone A; Pioli G; Girasole G; Razzano M; Pizzonia M; Pedrazzoni M; Palummeri E; Bianchi G
J Am Geriatr Soc; 2010 Aug; 58(8):1489-95. PubMed ID: 20646099
[TBL] [Abstract][Full Text] [Related]
8. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.
Alvarez JA; Law J; Coakley KE; Zughaier SM; Hao L; Shahid Salles K; Wasse H; Gutiérrez OM; Ziegler TR; Tangpricha V
Am J Clin Nutr; 2012 Sep; 96(3):672-9. PubMed ID: 22854402
[TBL] [Abstract][Full Text] [Related]
9. Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial.
Pérez-Castrillón JL; Dueñas-Laita A; Brandi ML; Jódar E; Del Pino-Montes J; Quesada-Gómez JM; Cereto Castro F; Gómez-Alonso C; Gallego López L; Olmos Martínez JM; Alhambra Expósito MR; Galarraga B; González-Macías J; Bouillon R; Hernández-Herrero G; Fernández-Hernando N; Arranz-Gutiérrez P; Chinchilla SP
J Bone Miner Res; 2021 Oct; 36(10):1967-1978. PubMed ID: 34101900
[TBL] [Abstract][Full Text] [Related]
10. Effect of isolated vitamin D supplementation on bone turnover markers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial.
Nahas-Neto J; Cangussu LM; Orsatti CL; Bueloni-Dias FN; Poloni PF; Schmitt EB; Nahas EAP
Osteoporos Int; 2018 May; 29(5):1125-1133. PubMed ID: 29450585
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Vitamin D Supplementation on Bone Metabolic Markers in Chronic Kidney Disease.
Yadav AK; Kumar V; Kumar V; Banerjee D; Gupta KL; Jha V
J Bone Miner Res; 2018 Mar; 33(3):404-409. PubMed ID: 29044707
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of risedronate with cholecalciferol on bone mineral density in Korean patients with osteoporosis.
Park SY; Kang MI; Park HM; Rhee Y; Moon SH; Yoon HK; Koh JM; Chang JS; Kim IJ; Won YY; Park YS; Choi H; Shin CS; Yoon TR; Yun SC; Chung HY;
Arch Osteoporos; 2019 Dec; 15(1):3. PubMed ID: 31820121
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
14. Bone mass preservation with high-dose cholecalciferol and dietary calcium in HIV patients following antiretroviral therapy. Is it possible?
Mela Q; Ruggiero V; Montaldo L; Pisano U; Matta L; Maria Pasetto C; Onali S; Cacace E; Carta MG; Barca L; Chessa L
HIV Clin Trials; 2018 Oct; 19(5):188-196. PubMed ID: 30445888
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D supplementation after parathyroidectomy: effect on bone mineral density-a randomized double-blind study.
Norenstedt S; Pernow Y; Zedenius J; Nordenström J; Sääf M; Granath F; Nilsson IL
J Bone Miner Res; 2014 Apr; 29(4):960-7. PubMed ID: 24115138
[TBL] [Abstract][Full Text] [Related]
16. VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial.
Courbebaisse M; Alberti C; Colas S; Prié D; Souberbielle JC; Treluyer JM; Thervet E
Trials; 2014 Nov; 15():430. PubMed ID: 25376735
[TBL] [Abstract][Full Text] [Related]
17. The effect of high-dose vitamin D supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin d: results from a randomized controlled study.
Wamberg L; Pedersen SB; Richelsen B; Rejnmark L
Calcif Tissue Int; 2013 Jul; 93(1):69-77. PubMed ID: 23591713
[TBL] [Abstract][Full Text] [Related]
18. Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: a 1-year double-blind RCT in postmenopausal women.
Macdonald HM; Wood AD; Aucott LS; Black AJ; Fraser WD; Mavroeidi A; Reid DM; Secombes KR; Simpson WG; Thies F
J Bone Miner Res; 2013 Oct; 28(10):2202-13. PubMed ID: 23585346
[TBL] [Abstract][Full Text] [Related]
19. The effect of low-dose cholecalciferol and calcium treatment on posttransplant bone loss in renal transplant patients: a prospective study.
Sahin G; Yasar NS; Sirmagul B; Bal C; Yalcin AU
Ren Fail; 2008; 30(10):992-9. PubMed ID: 19016151
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of weekly administration of cholecalciferol on parathyroid hormone in stable kidney-transplanted patients with CKD stage 1-3.
Sella S; Bonfante L; Fusaro M; Neri F; Plebani M; Zaninotto M; Aghi A; Innico G; Tripepi G; Michielin A; Prandini T; Calò LA; Giannini S
Clin Chem Lab Med; 2020 May; 59(2):343-351. PubMed ID: 32374278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
